Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carina Wenzel

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Immunology|December 24, 2024
Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture systemChristina Völzke, Lisa Ehrhardt, Laura Fischer, et al.
HGG Advances|May 23, 2022
Stx4 is required to regulate cardiomyocyte Ca<sup>2+</sup> handling during vertebrate cardiac developmentEliyahu Perl, Padmapriyadarshini Ravisankar, Manu E Beerens, et al.
Clinical Lung Cancer|April 29, 2026
A Retrospective, Multicenter Analysis Within the National Network Genomic Medicine Lung Cancer in Germany to Detect RET Fusions as a Possible Mechanism of Resistance in Patients With EGFR MutationsCornelia Kropf-Sanchen, Nikolaj Frost, Jonas Kuon, et al.
British Journal of Cancer|January 25, 2025
Extracellular vesicles from pancreatic cancer and its tumour microenvironment promote increased Schwann cell migrationFang Cheng Wong, Sebastian R Merker, Lisa Bauer, et al.
Molecular Cancer|January 10, 2024
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based thresholdTim Schmäche, Juliane Fohgrub, Anna Klimova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2021
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 MutationsFelix C Saalfeld, Carina Wenzel, Petros Christopoulos, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2024
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapyFelix Carl Saalfeld, Johanna Möller, Petros Christopoulos, et al.
NPJ Precision Oncology|June 29, 2026
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysisMarie-Elisabeth Leßmann, Felix Carl Saalfeld, Lea Ruge, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Immunology|December 24, 2024
Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture systemChristina Völzke, Lisa Ehrhardt, Laura Fischer, et al.
HGG Advances|May 23, 2022
Stx4 is required to regulate cardiomyocyte Ca<sup>2+</sup> handling during vertebrate cardiac developmentEliyahu Perl, Padmapriyadarshini Ravisankar, Manu E Beerens, et al.
Clinical Lung Cancer|April 29, 2026
A Retrospective, Multicenter Analysis Within the National Network Genomic Medicine Lung Cancer in Germany to Detect RET Fusions as a Possible Mechanism of Resistance in Patients With EGFR MutationsCornelia Kropf-Sanchen, Nikolaj Frost, Jonas Kuon, et al.
British Journal of Cancer|January 25, 2025
Extracellular vesicles from pancreatic cancer and its tumour microenvironment promote increased Schwann cell migrationFang Cheng Wong, Sebastian R Merker, Lisa Bauer, et al.
Molecular Cancer|January 10, 2024
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based thresholdTim Schmäche, Juliane Fohgrub, Anna Klimova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2021
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 MutationsFelix C Saalfeld, Carina Wenzel, Petros Christopoulos, et al.
European Journal of Cancer (Oxford, England : 1990)|October 18, 2024
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapyFelix Carl Saalfeld, Johanna Möller, Petros Christopoulos, et al.
NPJ Precision Oncology|June 29, 2026
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysisMarie-Elisabeth Leßmann, Felix Carl Saalfeld, Lea Ruge, et al.
Pageof 2